The development of an injectable hydrogel from human lipoaspirate represents a minimally invasive option for adipose tissue engineering in terms of both the collection of source material and delivery of the scaffold.
The current study describes the development of an injectable, porous PLGA scaffold that solidifies in situ at 37 °C.
This research identified strong support for the development of a longer-acting injectable contraceptive method for multiple reasons.
Here we review past applications of drug delivery technologies to injectable contraceptives as well as recent advancements in sustained drug delivery technologies that hold promise for the development of a new longer-acting injectable contraceptive product.
The ability of reactive two-component PUR scaffolds to promote new tissue formation in vivo through local delivery of PDGF may present compelling opportunities for the development of novel injectable therapeutics.
Here we present a generic strategy for modulating cytokine function and focus on the preclinical development of an injectable anti-IL-6 peptide for the treatment of RA.
Here, we report results toward the development of a reproducible manufacturing process for tissue engineering scaffolds based on injectable porogens fabricated by DDP.
The development of the BION injectable neurostimulators exemplifies a challenging, but well posed medical design problem addressed with a successful strategy for prioritizing and resolving the biomedical and technological challenges.
This study describes the development of injectable microcapsules for the delivery of mesenchymal stem cells (MSCs) into the infarcted cardiac wall.
The development of long-acting, injectable atypical antipsychotics has provided a new paradigm for schizophrenia treatment.
